|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 07, 2021 04:19PM
|
|
Novartis & Pfizer withdraw drug application in Europe
|
4
|
Resverlogix Corp.
|
Dec 23, 2018 09:20AM
|
|
What's up?
|
4
|
Resverlogix Corp.
|
May 24, 2023 11:50AM
|
|
Re: Why such little intrest, so close to the finis
|
4
|
Resverlogix Corp.
|
Nov 17, 2018 08:14AM
|
|
Re: Don't look now but...
|
4
|
Resverlogix Corp.
|
May 08, 2019 10:03AM
|
|
Re: Naz listing?
|
4
|
Resverlogix Corp.
|
Apr 20, 2019 09:04AM
|
|
Re: early report imo
|
4
|
Resverlogix Corp.
|
Jul 04, 2022 03:57PM
|
|
Re: NASDAQ here we come!!!
|
4
|
Resverlogix Corp.
|
Apr 23, 2019 12:42PM
|
|
Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
4
|
Resverlogix Corp.
|
Jun 12, 2023 07:23AM
|
|
Re: Reminds me of.......
|
4
|
Resverlogix Corp.
|
Jun 25, 2019 10:12AM
|
|
Re: Trading
|
4
|
Resverlogix Corp.
|
Aug 30, 2024 10:10AM
|
|
Shenzhen Hepalink-Warrants Expiration
|
4
|
Resverlogix Corp.
|
Feb 04, 2022 11:19AM
|
|
Re: Some history
|
4
|
Resverlogix Corp.
|
Jan 25, 2023 08:49AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 10, 2022 12:50PM
|
|
HL Acquires Additional Securities of RVX
|
4
|
Resverlogix Corp.
|
May 22, 2021 06:55AM
|
|
Re: Anyone care to take a stab at the cash situation?
|
4
|
Resverlogix Corp.
|
Oct 02, 2019 07:49AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
4
|
Resverlogix Corp.
|
May 03, 2021 05:57AM
|
|
Re: OTC Short Interest drops significantly from 729,105 to 475,882 -34.80% as of 03/31
|
4
|
Resverlogix Corp.
|
Apr 20, 2022 07:28PM
|
|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 14, 2019 05:43AM
|
|
Re: TNBC no longer active?
|
4
|
Zenith Epigenetics
|
Jul 02, 2023 12:30PM
|
